Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG

---

Publications & Presentations

76. Tieu J D, Hopps S, Miller J L, Kupiec K E, Skrepnek G H, Liu C, Smith W J. Clostridium difficile treatment in neutropenic patients: Clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 2017

77. Hughes K M, Johnson P N, Anderson M P, Sekar K C, Welliver R C, Miller J L. Comparison of Amikacin Pharmacokinetics in Neonates Following Implementation of a New Dosage Protocol. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2017; 22 : 33-40

78. Hughes K M, Johnson P N, Anderson M, Sekar K C, Welliver R C, Miller J L. Comparison of Amikacin Pharmacokinetics in Neonates Following Implementation of a New Dosage Protocol. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2017; 22 : 33-40

79. Capino A C, Miller J L, Johnson P N. Clonidine for Sedation and Analgesia and Withdrawal in Critically Ill Infants and Children. Pharmacotherapy. 2016; 36 : 1290-1299

80. Ibach B W, Johnson P N, Ernst K D, Harrison D, Miller J L. Initial dosing and taper complexity of methadone and morphine for treatment of neonatal abstinence syndrome. Journal of Pharmacy Technology. 2016; 32 : 216-22

Grants

1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.

Awards and Honors

1. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.


2. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.


3. Pediatric Pharmacy Association. Christensen Memorial Young Investigator Award Nominee (Resident Mentor). Date: 2022.


4. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2019.


5. University of Oklahoma College of Pharmacy; Department of Clinical and Administrative Sciences. Best Paper Award. Date: 2018.

Education

1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.


2. Degree: BS. Trevecca Nazarene University. Date: 2002.

Administrative Assignments

1. Role: Department Vice-Chair. Scope: Department. Date: 2021.

Read More